30 East 60th Street | Suite 302
New York, New York 10022

 

212.787.1877

© 2018 Dr. Dana Cohen. Created with pride by Ricochet Marketing

Follow Me

February 28, 2017

If you or a loved one is a diabetic over 50 who has suffered a heart attack, there's an opportunity to obtain a potentially lifesaving therapy AT NO CHARGE. Dr. Dana Cohen describes the TACT2 trial, a multi-million dollar government-sponsored study to evaluate the effectiveness of chelation therapy. What is chelation? What is its history? How did the first TACT study demonstrate its effectiveness? Why was it greeted with skepticism by the medical establishment? Why have only integrative doctors been eager to embrace chelation?

CLICK HERE TO LISTEN TO PODCASTS 1 & 2

November 29, 2016

Second study will focus on benefits of removing toxic metal pollutants in patients with diabetes and a prior heart attack

Dana G. Cohen, MD has been named a participating clinical site for the second Trial to Assess Chelation Therapy (TACT2). TACT2 will examine the use of intravenous chelation treatments in combination with oral vitamins in diabetic patients with a prior heart attack to determine if they reduce recurrent heart episodes, such as heart attacks, stroke, death, and others, by removing toxins from the blood.

Funding for TACT2 was announced in September of 2016 when The National Center for Complementary and Integrative Health (NCCIH) of the National Institutes of Health (NIH) awarded $37M to initiate the trial. The trial is also co-funded by the National Heart, Lung and Blood Institute, the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Environmental Health Sciences. 

Chelation is a process by which a medication, such as edetate d...

November 15, 2016

Our Integrative Medicine blog will be posting soon - please return at a later date for our exciting posts!

Please reload

  • Grey Facebook Icon
  • Grey Twitter Icon
  • Grey Instagram Icon
  • Grey Pinterest Icon
Featured Posts

Second study will focus on benefits of removing toxic metal pollutants in patients with diabetes and a prior heart attack

Dana G. Cohen, MD has been na...

Dr. Cohen to Participate in National Institutes of Health TACT2 Research Trial

November 29, 2016

1/1
Please reload

Blog Archive
Please reload

Blog

Newsletter Archive

February 2017
January 2017
December 2016
September 2016
August 2016